Ensign Peak Advisors
PRVL

Ensign Peak Advisors’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Ensign Peak Advisors’s Portfolio PRVL Stock Details PRVL Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-28,143
Closed -$286K – 1900
2020
Q3 		$286K Buy
+28,143
New +$286K ﹤0.01% 1628